Copyright Reports & Markets. All rights reserved.

Global Friedreich Ataxia Drug Sales Market Report 2019

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Friedreich Ataxia Drug Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Friedreich Ataxia Drug Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Friedreich Ataxia Drug Market Size Growth Rate by Type
    • 1.4.2 ADVM-063
    • 1.4.3 AGIL-FA
    • 1.4.4 BHV-4157
    • 1.4.5 BVA-202
    • 1.4.6 Others
  • 1.5 Market by Application
    • 1.5.1 Global Friedreich Ataxia Drug Market Size Growth Rate by Application
    • 1.5.2 Clinic
    • 1.5.3 Hospital
    • 1.5.4 Others
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Friedreich Ataxia Drug Market Size, Estimates and Forecasts
    • 2.1.1 Global Friedreich Ataxia Drug Revenue 2015-2026
    • 2.1.2 Global Friedreich Ataxia Drug Sales 2015-2026
  • 2.2 Global Friedreich Ataxia Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
    • 2.2.1 Global Friedreich Ataxia Drug Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Friedreich Ataxia Drug Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Friedreich Ataxia Drug Competitor Landscape by Players

  • 3.1 Friedreich Ataxia Drug Sales by Manufacturers
    • 3.1.1 Friedreich Ataxia Drug Sales by Manufacturers (2015-2020)
    • 3.1.2 Friedreich Ataxia Drug Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Friedreich Ataxia Drug Revenue by Manufacturers
    • 3.2.1 Friedreich Ataxia Drug Revenue by Manufacturers (2015-2020)
    • 3.2.2 Friedreich Ataxia Drug Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Friedreich Ataxia Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Friedreich Ataxia Drug Revenue in 2019
    • 3.2.5 Global Friedreich Ataxia Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Friedreich Ataxia Drug Price by Manufacturers
  • 3.4 Friedreich Ataxia Drug Manufacturing Base Distribution, Product Types
    • 3.4.1 Friedreich Ataxia Drug Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Friedreich Ataxia Drug Product Type
    • 3.4.3 Date of International Manufacturers Enter into Friedreich Ataxia Drug Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Friedreich Ataxia Drug Market Size by Type (2015-2020)
    • 4.1.1 Global Friedreich Ataxia Drug Sales by Type (2015-2020)
    • 4.1.2 Global Friedreich Ataxia Drug Revenue by Type (2015-2020)
    • 4.1.3 Friedreich Ataxia Drug Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Friedreich Ataxia Drug Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Friedreich Ataxia Drug Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Friedreich Ataxia Drug Revenue Forecast by Type (2021-2026)
    • 4.2.3 Friedreich Ataxia Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Friedreich Ataxia Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Friedreich Ataxia Drug Market Size by Application (2015-2020)
    • 5.1.1 Global Friedreich Ataxia Drug Sales by Application (2015-2020)
    • 5.1.2 Global Friedreich Ataxia Drug Revenue by Application (2015-2020)
    • 5.1.3 Friedreich Ataxia Drug Price by Application (2015-2020)
  • 5.2 Friedreich Ataxia Drug Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Friedreich Ataxia Drug Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Friedreich Ataxia Drug Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Friedreich Ataxia Drug Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Friedreich Ataxia Drug by Country
    • 6.1.1 North America Friedreich Ataxia Drug Sales by Country
    • 6.1.2 North America Friedreich Ataxia Drug Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Friedreich Ataxia Drug Market Facts & Figures by Type
  • 6.3 North America Friedreich Ataxia Drug Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Friedreich Ataxia Drug by Country
    • 7.1.1 Europe Friedreich Ataxia Drug Sales by Country
    • 7.1.2 Europe Friedreich Ataxia Drug Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Friedreich Ataxia Drug Market Facts & Figures by Type
  • 7.3 Europe Friedreich Ataxia Drug Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Friedreich Ataxia Drug by Region
    • 8.1.1 Asia Pacific Friedreich Ataxia Drug Sales by Region
    • 8.1.2 Asia Pacific Friedreich Ataxia Drug Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Friedreich Ataxia Drug Market Facts & Figures by Type
  • 8.3 Asia Pacific Friedreich Ataxia Drug Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Friedreich Ataxia Drug by Country
    • 9.1.1 Latin America Friedreich Ataxia Drug Sales by Country
    • 9.1.2 Latin America Friedreich Ataxia Drug Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Friedreich Ataxia Drug Market Facts & Figures by Type
  • 9.3 Central & South America Friedreich Ataxia Drug Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Friedreich Ataxia Drug by Country
    • 10.1.1 Middle East and Africa Friedreich Ataxia Drug Sales by Country
    • 10.1.2 Middle East and Africa Friedreich Ataxia Drug Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Friedreich Ataxia Drug Market Facts & Figures by Type
  • 10.3 Middle East and Africa Friedreich Ataxia Drug Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Adverum Biotechnologies Inc
    • 11.1.1 Adverum Biotechnologies Inc Corporation Information
    • 11.1.2 Adverum Biotechnologies Inc Description and Business Overview
    • 11.1.3 Adverum Biotechnologies Inc Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Adverum Biotechnologies Inc Friedreich Ataxia Drug Products Offered
    • 11.1.5 Adverum Biotechnologies Inc Related Developments
  • 11.2 BioMarin Pharmaceutical Inc.
    • 11.2.1 BioMarin Pharmaceutical Inc. Corporation Information
    • 11.2.2 BioMarin Pharmaceutical Inc. Description and Business Overview
    • 11.2.3 BioMarin Pharmaceutical Inc. Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 BioMarin Pharmaceutical Inc. Friedreich Ataxia Drug Products Offered
    • 11.2.5 BioMarin Pharmaceutical Inc. Related Developments
  • 11.3 Biovista Inc.
    • 11.3.1 Biovista Inc. Corporation Information
    • 11.3.2 Biovista Inc. Description and Business Overview
    • 11.3.3 Biovista Inc. Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Biovista Inc. Friedreich Ataxia Drug Products Offered
    • 11.3.5 Biovista Inc. Related Developments
  • 11.4 Cardero Therapeutics Inc
    • 11.4.1 Cardero Therapeutics Inc Corporation Information
    • 11.4.2 Cardero Therapeutics Inc Description and Business Overview
    • 11.4.3 Cardero Therapeutics Inc Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Cardero Therapeutics Inc Friedreich Ataxia Drug Products Offered
    • 11.4.5 Cardero Therapeutics Inc Related Developments
  • 11.5 Catabasis Pharmaceuticals, Inc.
    • 11.5.1 Catabasis Pharmaceuticals, Inc. Corporation Information
    • 11.5.2 Catabasis Pharmaceuticals, Inc. Description and Business Overview
    • 11.5.3 Catabasis Pharmaceuticals, Inc. Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Catabasis Pharmaceuticals, Inc. Friedreich Ataxia Drug Products Offered
    • 11.5.5 Catabasis Pharmaceuticals, Inc. Related Developments
  • 11.6 Forward Pharma A/S
    • 11.6.1 Forward Pharma A/S Corporation Information
    • 11.6.2 Forward Pharma A/S Description and Business Overview
    • 11.6.3 Forward Pharma A/S Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Forward Pharma A/S Friedreich Ataxia Drug Products Offered
    • 11.6.5 Forward Pharma A/S Related Developments
  • 11.7 Ixchel Pharma LLC
    • 11.7.1 Ixchel Pharma LLC Corporation Information
    • 11.7.2 Ixchel Pharma LLC Description and Business Overview
    • 11.7.3 Ixchel Pharma LLC Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Ixchel Pharma LLC Friedreich Ataxia Drug Products Offered
    • 11.7.5 Ixchel Pharma LLC Related Developments
  • 11.8 Pfizer Inc
    • 11.8.1 Pfizer Inc Corporation Information
    • 11.8.2 Pfizer Inc Description and Business Overview
    • 11.8.3 Pfizer Inc Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 Pfizer Inc Friedreich Ataxia Drug Products Offered
    • 11.8.5 Pfizer Inc Related Developments
  • 11.9 ProQR Therapeutics NV
    • 11.9.1 ProQR Therapeutics NV Corporation Information
    • 11.9.2 ProQR Therapeutics NV Description and Business Overview
    • 11.9.3 ProQR Therapeutics NV Sales, Revenue and Gross Margin (2015-2020)
    • 11.9.4 ProQR Therapeutics NV Friedreich Ataxia Drug Products Offered
    • 11.9.5 ProQR Therapeutics NV Related Developments
  • 11.10 RaNA Therapeutics Inc
    • 11.10.1 RaNA Therapeutics Inc Corporation Information
    • 11.10.2 RaNA Therapeutics Inc Description and Business Overview
    • 11.10.3 RaNA Therapeutics Inc Sales, Revenue and Gross Margin (2015-2020)
    • 11.10.4 RaNA Therapeutics Inc Friedreich Ataxia Drug Products Offered
    • 11.10.5 RaNA Therapeutics Inc Related Developments
  • 11.1 Adverum Biotechnologies Inc
    • 11.1.1 Adverum Biotechnologies Inc Corporation Information
    • 11.1.2 Adverum Biotechnologies Inc Description and Business Overview
    • 11.1.3 Adverum Biotechnologies Inc Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Adverum Biotechnologies Inc Friedreich Ataxia Drug Products Offered
    • 11.1.5 Adverum Biotechnologies Inc Related Developments
  • 11.12 Retrotope Inc
    • 11.12.1 Retrotope Inc Corporation Information
    • 11.12.2 Retrotope Inc Description and Business Overview
    • 11.12.3 Retrotope Inc Sales, Revenue and Gross Margin (2015-2020)
    • 11.12.4 Retrotope Inc Products Offered
    • 11.12.5 Retrotope Inc Related Developments
  • 11.13 Takeda
    • 11.13.1 Takeda Corporation Information
    • 11.13.2 Takeda Description and Business Overview
    • 11.13.3 Takeda Sales, Revenue and Gross Margin (2015-2020)
    • 11.13.4 Takeda Products Offered
    • 11.13.5 Takeda Related Developments
  • 11.14 STATegics Inc
    • 11.14.1 STATegics Inc Corporation Information
    • 11.14.2 STATegics Inc Description and Business Overview
    • 11.14.3 STATegics Inc Sales, Revenue and Gross Margin (2015-2020)
    • 11.14.4 STATegics Inc Products Offered
    • 11.14.5 STATegics Inc Related Developments
  • 11.15 Voyager Therapeutics Inc
    • 11.15.1 Voyager Therapeutics Inc Corporation Information
    • 11.15.2 Voyager Therapeutics Inc Description and Business Overview
    • 11.15.3 Voyager Therapeutics Inc Sales, Revenue and Gross Margin (2015-2020)
    • 11.15.4 Voyager Therapeutics Inc Products Offered
    • 11.15.5 Voyager Therapeutics Inc Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Friedreich Ataxia Drug Market Estimates and Projections by Region
    • 12.1.1 Global Friedreich Ataxia Drug Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Friedreich Ataxia Drug Revenue Forecast by Regions 2021-2026
  • 12.2 North America Friedreich Ataxia Drug Market Size Forecast (2021-2026)
    • 12.2.1 North America: Friedreich Ataxia Drug Sales Forecast (2021-2026)
    • 12.2.2 North America: Friedreich Ataxia Drug Revenue Forecast (2021-2026)
    • 12.2.3 North America: Friedreich Ataxia Drug Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Friedreich Ataxia Drug Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Friedreich Ataxia Drug Sales Forecast (2021-2026)
    • 12.3.2 Europe: Friedreich Ataxia Drug Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Friedreich Ataxia Drug Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Friedreich Ataxia Drug Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Friedreich Ataxia Drug Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Friedreich Ataxia Drug Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Friedreich Ataxia Drug Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Friedreich Ataxia Drug Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Friedreich Ataxia Drug Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Friedreich Ataxia Drug Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Friedreich Ataxia Drug Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Friedreich Ataxia Drug Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Friedreich Ataxia Drug Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Friedreich Ataxia Drug Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Friedreich Ataxia Drug Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter's Five Forces Analysis
  • 13.5 Primary Interviews with Key Friedreich Ataxia Drug Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Friedreich Ataxia Drug Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Friedreich Ataxia Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Friedreich Ataxia Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

    Segment by Type, the Friedreich Ataxia Drug market is segmented into
    ADVM-063
    AGIL-FA
    BHV-4157
    BVA-202
    Others

    Segment by Application, the Friedreich Ataxia Drug market is segmented into
    Clinic
    Hospital
    Others

    Regional and Country-level Analysis
    The Friedreich Ataxia Drug market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Friedreich Ataxia Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
    Competitive Landscape and Friedreich Ataxia Drug Market Share Analysis
    Friedreich Ataxia Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Friedreich Ataxia Drug business, the date to enter into the Friedreich Ataxia Drug market, Friedreich Ataxia Drug product introduction, recent developments, etc.

    The major vendors covered:
    Adverum Biotechnologies Inc
    BioMarin Pharmaceutical Inc.
    Biovista Inc.
    Cardero Therapeutics Inc
    Catabasis Pharmaceuticals, Inc.
    Forward Pharma A/S
    Ixchel Pharma LLC
    Pfizer Inc
    ProQR Therapeutics NV
    RaNA Therapeutics Inc
    Reata Pharmaceuticals Inc
    Retrotope Inc
    Takeda
    STATegics Inc
    Voyager Therapeutics Inc

    Buy now